Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Achilles Therapeutics Plc ADR’s current trading price is -32.39% away from its 52-week high, while its distance from the 52-week low is 88.89%. The stock’s price range during this period has varied between $0.63 and $1.76. The company, active in the Healthcare sector, saw a trading volume of around 0.25 million for the day, considerably higher average daily volume of 0.17 million observed over the last three months.
The market performance of Achilles Therapeutics Plc ADR has been somewhat stable. Over the past year, the company’s stock achieved a high of $1.76 on 02/29/24, with the lowest value for the same timeframe being $0.63, recorded on 08/28/24.
How Financial Performance Impacts Market Capitalization
Achilles Therapeutics Plc ADR (ACHL) has experienced a quarterly rise of 16.67% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 48.91M and boasts a workforce of 215 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.9628, with a change in price of +0.4500. Similarly, Achilles Therapeutics Plc ADR recorded 499,862 in trading volume during the last 100 days, posting a change of +60.81%.
How ACHL’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for ACHL stands at 0.04. Similarly, the long-term debt-to-equity ratio is also 0.00.
ACHL Stock Stochastic Average
As of today, the raw stochastic average of Achilles Therapeutics Plc ADR over the past 50 days is 96.40%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 96.40%. Additionally, the Stochastic %K and %D values for the company were 93.87% and 90.49%, respectively, over the past 20 days.
ACHL Stock Price Performance Analysis
Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. The metric has seen a significant gain of 4.39% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 41.67%. Over the past 30 days, the price of ACHL has fallen by 14.42%. And in the last five days, it has surged by 4.39%.
